With the House successfully passing President Joe Biden’s $1.9 trillion COVID-19 relief bill, it is now in the hands of the Senate. Biden makes another strong push for the passage of the bill in his latest meeting with Senate Democrats.
Biden sat down with Senate Democrats in a virtual meeting Tuesday to talk about the sweeping COVID-19 relief package he has proposed. People knowledgeable of the meeting revealed to CNN that Biden told the Democratic lawmakers that in order to successfully pass the relief plan, they would need to accept some provisions that may not necessarily be favorable to them. Biden reportedly noted that they must show the American public that they are determined to respond to the ongoing pandemic and the economic collapse it has caused.
The President met with Senate Democrats for lunch for 15 minutes and did not take questions. Biden did not get into specifics with regards to the ongoing debates that are occurring within the Democrats in the upper chamber. The ongoing debates among Democrats have involved whether or not to reduce unemployment benefits to $300 a week from $400 a week as passed by the House. West Virginia Democrat Joe Manchin has said he supports the $300 a week level, but it has put him at odds with Delaware Senator Chris Coons, who opposed reducing the benefit.
Montana Democrat Jon Tester said that modest changes may ultimately be made to the COVID-19 relief plan in order for it to pass. Nevertheless, they all appear to agree not to reduce the overall cost of $1.9 trillion.
Meanwhile, Biden made an announcement regarding the COVID-19 vaccines. Biden announced that the US expects to be able to ship out enough COVID-19 vaccines for all adults until the end of May which is two months earlier than he had previously estimated. Biden also pushed for states to vaccinate teachers at least once by the end of March in order to speed up the reopenings of schools.
Pharmaceutical company Merck has also been announced to produce its rival Johnson & Johnson’s one-shot vaccine that has been recently approved by the FDA.


White House Shooting Reports Prompt Major Security Response in Washington, D.C.
Marco Rubio Visits India to Rebuild U.S.-India Ties Amid Trade and Geopolitical Tensions
U.S. Military Drill Over Caracas Raises Tensions in Venezuela
Wang Yi to Lead UN Security Council Meeting and Visit Canada Amid Improving China-Canada Relations
Xi Jinping Orders Full Rescue After Shanxi Coal Mine Gas Explosion Kills Eight
U.S. Sanctions Tanzanian Police Official Over Human Rights Violations
Trump-Lai Call Remains Uncertain as U.S.-China Tensions Over Taiwan Intensify
World Bank Emergency Funding Demand Surges as 27 Countries Seek Crisis Support Amid Iran Conflict
Iran-U.S. Talks Continue as Strait of Hormuz and Uranium Dispute Stall Peace Efforts
Trump Sends 5,000 Additional U.S. Troops to Poland Ahead of NATO Talks on Iran War
Trump Says Iran Peace Deal Could Reopen Strait of Hormuz as Nuclear Talks Advance
House Republicans Delay Vote on Iran War Powers Resolution Amid Growing Congressional Debate
Trump Signals Tough Stance on Iran Uranium Stockpile as Nuclear Talks Show Limited Progress
Rubio Says NATO Must Benefit All Members Ahead of Sweden Meeting
US Approves $108 Million Hawk Missile System Support Package for Ukraine
Russia Launches Massive Missile and Drone Strike on Kyiv Amid Oreshnik Threat
Trump’s White House Ballroom Project Draws Criticism Amid Rising Gas Prices 



